B-type natriuretic peptide (BNP) is a neurohormone produced mainly by ventricular
myocytes in response to increased left ventricular end-diastolic pressure. Patients with acute …

Background NT-proBNP is an important predictor of mortality but is inversely related to
estimated glomerular filtration rate (eGFR). Whether the prognostic value of NT-proBNP is …

BACKGROUND: Brain natriuretic peptide (BNP) is a cardiac hormone with vasodilating,
natriuretic, renin-angiotensin-aldosterone–inhibiting and lusitropic properties. We have …

BACKGROUND B-type natriuretic peptide (BNP) compensates for the failing heart and is
synthesized as a 108-residue prohormone that is cleaved to a 32-residue C-terminal …

B-type natriuretic peptide (BNP; Abbott Diagnostics) and N-terminal proBNP (NT-proBNP,
Roche Diagnostics) were compared in consecutive samples of 458 patients (mean age 60 …

Introduction The long-term effect of beta-blockade on the plasma levels of natriuretic
peptides BNP and its N-terminal counterpart, NT-proBNP, as risk markers in heart failure …

Background The prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP)
in heart failure (HF) is well-established. However, whether it could facilitate the risk …

Background: B‐type natriuretic peptide (BNP) and the inactive metabolite NT‐proBNP are
proven tests for diagnosis and staging of severity for patients with heart failure. However, the …

Background Although some patients with heart failure (HF) with mildly reduced/preserved
ejection fraction have low natriuretic peptide levels, there are no large-scale systematic …

BACKGROUND: Brain natriuretic peptide (BNP) levels correlate with outcomes in patients
with heart failure (HF). We sought to compare the relationship between absolute and relative …